Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent
Pharmaceuticals · 18.01.2024 · 17 (1) · 126
DOI: 10.3390/ph17010126 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 18.01.2024. Verfasst von Muhammad Ali und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Center 5 "National Biodiversity Future Center", theme "Bio-diversità", in the frame-work of the Piano Nazionale di Ripresa e resilienza, Mission 4 Com…, European Union—NextGenerationEU.
Abstract (Originalsprache)
Resveratrol is a polyphenolic compound that has gained considerable attention in the past decade due to its multifaceted therapeutic potential, including anti-inflammatory and anticancer properties. However, its anticancer efficacy is impeded by low water solubility, dose-limiting toxicity, low bioavailability, and rapid hepatic metabolism. To overcome these hurdles, various nanoparticles such as organic and inorganic nanoparticles, liposomes, polymeric nanoparticles, dendrimers, solid lipid nanoparticles, gold nanoparticles, zinc oxide nanoparticles, zeolitic imidazolate frameworks, carbon nanotubes, bioactive glass nanoparticles, and mesoporous nanoparticles were employed to deliver resveratrol, enhancing its water solubility, bioavailability, and efficacy against various types of cancer. Resveratrol-loaded nanoparticle or resveratrol-conjugated nanoparticle administration exhibits excellent anticancer potency compared to free resveratrol. This review highlights the latest developments in nanoparticle-based delivery systems for resveratrol, focusing on the potential to overcome limitations associated with the compound’s bioavailability and therapeutic effectiveness.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ri.MED Foundation, Via Bandiera 11, 90133 Palermo, Italy.
- Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, Molecular and Clinical Medicine, University of Palermo, 90127 Palermo, Italy.
- Department of Biomedicine, Neuroscience and Advanced Diagnostics, University of Palermo, 90127 Palermo, Italy.
- National Biodiversity Future Center (NBFC), 90133 Palermo, Italy.
ORCID-Profile: Muhammad Ali, Viviana Benfante, Domenico Di Raimondo, Giuseppe Salvaggio, Antonino Tuttolomondo, Albert Comelli
Förderung
- National Center 5 "National Biodiversity Future Center", theme "Bio-diversità", in the frame-work of the Piano Nazionale di Ripresa e resilienza, Mission 4 Com…
- European Union—NextGenerationEU
Zitieren
APA
Ali, M., Benfante, V., Di Raimondo, D., Salvaggio, G., Tuttolomondo, A., & Comelli, A. (2024). Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. Pharmaceuticals, 17(1), 126. https://doi.org/10.3390/ph17010126
Vancouver
Ali M, Benfante V, Di Raimondo D, Salvaggio G, Tuttolomondo A, Comelli A. Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. Pharmaceuticals. 2024;17(1):126. doi:10.3390/ph17010126
BibTeX
@article{Ali2024,
author = {Ali, Muhammad and Benfante, Viviana and Di Raimondo, Domenico and Salvaggio, Giuseppe and Tuttolomondo, Antonino and Comelli, Albert},
title = {Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {1},
pages = {126},
doi = {10.3390/ph17010126}
}
EUVIMED